Day: November 13, 2023

  Nørresundby, Denmark, 13 November 2023 Announcement no. 17/2023Preliminary results for 2022/23RTX updates its revenue and earnings expectations for the financial year 2022/23.Revenue DKK 783 million (vs. outlook DKK 700-760 million) EBITDA DKK 108 million (vs. outlook DKK 85-105 million)RTX experienced a strong orderbook for our products and services in 2022/23. The orderbook size was impacted by past years’ instability in global electronic supply, where lead times rapidly changed, first up to 18 months and then back to a normal level of 3 months. However, this has also resulted in high inventories at several of our larger customers. The global supply chain challenges normalized during the year, and we experienced shorter lead times of components and material at the end of the year, compared to what we have experienced in the...

NEW YORK, Nov. 13, 2023 (GLOBE NEWSWIRE) — Tony Skiadas, executive vice president and chief financial officer of Verizon (NYSE, Nasdaq: VZ), is scheduled to speak at the Morgan Stanley European Technology, Media and Telecom Conference on Wednesday, November 15, at 2:05 a.m. ET. His remarks will be webcast, with access instructions available on Verizon’s Investor Relations website, www.verizon.com/about/investors. Verizon Communications Inc. (NYSE, Nasdaq: VZ) was formed on June 30, 2000 and is one of the world’s leading providers of technology and communications services. Headquartered in New York City and with a presence around the world, Verizon generated revenues of $136.8 billion in 2022. The company offers data, video and voice services and solutions on its award-winning networks and platforms, delivering on customers’ demand...

Daymon report reveals consumers shifting to private brands, spurring new product and retail innovation IRVINE, Calif., Nov. 13, 2023 (GLOBE NEWSWIRE) — Advantage Solutions Inc. (NASDAQ: ADV), a leading provider of sales and marketing services to consumer goods manufacturers and retailers, today announced the release of its 2023 Private Brand Intelligence Report, a compilation of proprietary research, market data and subject matter expertise. The report, conducted by Daymon, the global experts in private brand development, indicates that 92% of consumers trust private brands as much as or more than national brands and 83% of consumers view private brands as a better value for their money than national brands. “Increasing levels of trust, quality and value are prompting consumers to flock to private brands in record fashion,” said...

KT-474 showed evidence of robust target degradation and pathway inhibition with a favorable safety profile in healthy volunteers and patients Trial showed encouraging impact on disease burden and symptoms in Hidradenitis Suppurativa (HS) and Atopic Dermatitis (AD), with a systemic anti-inflammatory effect observed in patients with moderate-to-severe disease Study is first published clinical trial using a heterobifunctional degrader Kymera’s partner Sanofi conducting Phase 2 clinical trials of KT-474 (SAR444656) in HS and AD WATERTOWN, Mass., Nov. 13, 2023 (GLOBE NEWSWIRE) — Kymera Therapeutics, Inc. (NASDAQ: KYMR), a clinical-stage biopharmaceutical company advancing a new class of small molecule medicines using targeted protein degradation (TPD), today announced that results from the positive Phase 1 clinical trial from its...

SAN DIEGO, Nov. 13, 2023 (GLOBE NEWSWIRE) — DMK Pharmaceuticals Corporation (NASDAQ: DMK), a commercial stage neuro-biotech company primarily focused on developing and commercializing products for the treatment of opioid overdose and substance use disorders, today announced the presentation of preclinical results comparing the effects of DPI-125 on opioid withdrawal behaviors to methadone and buprenorphine, the standard of care for opioid use disorder (OUD), in a poster session at the Society for Neuroscience Annual Meeting (SfN Neuroscience 2023) held November 11-13, 2023 in Washington D.C. DPI-125 is a novel, small-molecule triple (mu, delta and kappa) opioid receptor agonist, being developed for the treatment of opioid use disorder. “Only about 12% of patients receive treatment for OUD, despite the proven efficacy of current...

– A Prespecified, Exploratory Analysis of Participants Reports Those with Higher Baseline Inflammation More Likely to Experience a Major Cardiovascular Event (MACE), Cardiovascular Death, and All-Cause Mortality Compared to Those with the Lowest Inflammation – – 21.6% Reduction in Vascular Inflammatory Marker High Sensitivity C-reactive Protein (hsCRP) in Patients Taking Bempedoic Acid – – Results Simultaneously Published in Circulation – ANN ARBOR, Mich., Nov. 13, 2023 (GLOBE NEWSWIRE) — Esperion (NASDAQ: ESPR) today announced the presentation of results from a pre-specified, exploratory analysis of CLEAR Outcomes at the 2023 American Heart Association (AHA) Scientific Sessions. Results were also simultaneously published in Circulation which can be accessed here. “The analysis presented at AHA and published in Circulation highlights...

Uponor Corporation, Managers’ transactions, 13 November 2023 at 16:30 EET Uponor Corporation – Managers’ transactions: Hans Sohlström Transaction notification under Article 19 of EU Market Abuse Regulation. Person subject to the notification requirementName: Sohlström, HansPosition: Member of the Board/Deputy memberIssuer: Uponor CorporationLEI: 743700KA2GMSYJM3CM12 Notification type: INITIAL NOTIFICATIONReference number: 743700KA2GMSYJM3CM12_20231113135812_102 ____________________________________________ Transaction date: 2023-11-13Venue: XHELInstrument type: SHAREISIN: FI0009002158Nature of the transaction: DISPOSAL Transaction details(1): Volume: 6,666 Unit price: 28.50 EUR Aggregated transactions(1): Volume: 6,666 Volume weighted average price: 28.50 EUR Further information:Franciska JanzonSenior Vice President, Corporate Communications...

YOKNEAM ILLIT, ISRAEL, Nov. 13, 2023 (GLOBE NEWSWIRE) —  Wearable Devices Ltd. (the “Company” or “Wearable Devices”) (Nasdaq: WLDS, WLDSW), a technology growth company specializing in AI-powered touchless sensing wearables, today announced the closing of a firm commitment underwritten public offering with gross proceeds to the Company of $2.0 million, before deducting underwriting discounts and other expenses paid by the Company. The base offering consisted of 4,444,444 ordinary shares priced to the public at $0.45 per share. The Company intends to use the proceeds from this offering for working capital and general corporate purposes. In addition, the Company granted Aegis Capital Corp. a 45-day option to purchase ordinary shares of up to 15% of the number of ordinary shares sold in the offering solely to cover over-allotments,...

Uponor Corporation, Managers’ transactions, 13 November 2023 at 16:25 EET Uponor Corporation – Managers’ transactions: Susanne Skippari Transaction notification under Article 19 of EU Market Abuse Regulation. Person subject to the notification requirementName: Skippari, SusannePosition: Member of the Board/Deputy memberIssuer: Uponor CorporationLEI: 743700KA2GMSYJM3CM12 Notification type: INITIAL NOTIFICATIONReference number: 743700KA2GMSYJM3CM12_20231113135812_98 ____________________________________________ Transaction date: 2023-11-13Venue: XHELInstrument type: SHAREISIN: FI0009002158Nature of the transaction: DISPOSAL Transaction details(1): Volume: 2,026 Unit price: 28.50 EUR Aggregated transactions(1): Volume: 2,026 Volume weighted average price: 28.50 EUR Further information:Franciska JanzonSenior Vice President, Corporate Communications...